Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 7 studies | 34% ± 9% | |
smooth muscle cell | 7 studies | 23% ± 6% | |
astrocyte | 6 studies | 29% ± 13% | |
epithelial cell | 5 studies | 24% ± 8% | |
endothelial cell | 4 studies | 26% ± 9% | |
cardiac muscle cell | 4 studies | 22% ± 4% | |
interneuron | 4 studies | 36% ± 20% | |
GABAergic neuron | 4 studies | 32% ± 16% | |
myofibroblast cell | 3 studies | 18% ± 3% | |
glutamatergic neuron | 3 studies | 39% ± 14% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 541.92 | 459 / 459 | 100% | 9.70 | 1115 / 1118 |
esophagus | 100% | 896.36 | 1441 / 1445 | 100% | 11.25 | 183 / 183 |
prostate | 100% | 710.69 | 244 / 245 | 100% | 10.56 | 502 / 502 |
pancreas | 100% | 1390.38 | 328 / 328 | 99% | 5.45 | 177 / 178 |
intestine | 100% | 767.37 | 966 / 966 | 99% | 6.95 | 524 / 527 |
stomach | 100% | 797.91 | 359 / 359 | 99% | 7.20 | 284 / 286 |
uterus | 100% | 749.10 | 170 / 170 | 99% | 8.96 | 455 / 459 |
lung | 99% | 463.62 | 572 / 578 | 100% | 8.58 | 1152 / 1155 |
bladder | 100% | 884.48 | 21 / 21 | 98% | 6.85 | 496 / 504 |
ovary | 100% | 661.46 | 180 / 180 | 97% | 5.65 | 418 / 430 |
thymus | 100% | 570.48 | 650 / 653 | 97% | 6.34 | 589 / 605 |
skin | 100% | 843.04 | 1807 / 1809 | 90% | 5.18 | 423 / 472 |
adrenal gland | 100% | 601.31 | 258 / 258 | 83% | 3.67 | 191 / 230 |
brain | 82% | 256.73 | 2167 / 2642 | 92% | 3.81 | 651 / 705 |
kidney | 90% | 275.53 | 80 / 89 | 80% | 3.04 | 718 / 901 |
liver | 63% | 156.62 | 143 / 226 | 84% | 3.76 | 340 / 406 |
adipose | 100% | 567.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1351.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1359.10 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.18 | 1 / 1 |
spleen | 93% | 252.34 | 224 / 241 | 0% | 0 | 0 / 0 |
heart | 90% | 456.18 | 771 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 2.08 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 45% | 1.74 | 36 / 80 |
peripheral blood | 23% | 161.01 | 213 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0006486 | Biological process | protein glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008376 | Molecular function | acetylgalactosaminyltransferase activity |
GO_0008194 | Molecular function | UDP-glycosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | B3GALNT2 |
Protein name | Beta-1,3-N-acetylgalactosaminyltransferase 2 UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (Beta-1,3-GalNAc-T2) (EC 2.4.1.313) (Beta-1,3-N-acetylgalactosaminyltransferase II) Hexosyltransferase (EC 2.4.1.-) |
Synonyms | |
Description | FUNCTION: Beta-1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. Has no galactose nor galactosaminyl transferase activity toward any acceptor substrate. Involved in alpha-dystroglycan (DAG1) glycosylation: acts coordinately with GTDC2/POMGnT2 to synthesize a GalNAc-beta3-GlcNAc-beta-terminus at the 4-position of protein O-mannose in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan, which is required for binding laminin G-like domain-containing extracellular proteins with high affinity. . |
Accessions | ENST00000366600.8 [Q8NCR0-1] ENST00000675555.1 ENST00000676288.1 A0A6Q8PEZ9 ENST00000635244.1 [Q8NCR0-2] A0A087WY64 ENST00000313984.3 [Q8NCR0-2] A0A6Q8PGQ3 ENST00000635453.2 [Q8NCR0-1] Q8NCR0 ENST00000675193.1 ENST00000612859.4 A0A6Q8PG34 ENST00000635195.1 |